Impact of Intracranial Hemorrhage After Endovascular Treatment for Medium Vessel Occlusion

Satoru Fujiwara1, Kazutaka Uchida2, Tsuyoshi Ohta3

  • 1Department of Neurology, Kobe City Medical Center General Hospital, Kobe , Japan.

Neurosurgery
|March 14, 2025
PubMed
Abstract

Insights

Intracranial hemorrhage (ICH) after endovascular treatment (EVT) for medium vessel occlusion (MeVO) is linked to poorer functional outcomes. Minimizing ICH during EVT for MeVO is essential for improving patient results.

Area of Science:

  • Neurology
  • Interventional Neuroradiology
  • Stroke Medicine

Background:

  • Endovascular treatment (EVT) is used for acute ischemic stroke due to medium vessel occlusion (MeVO).
  • Hemorrhagic complications, specifically intracranial hemorrhage (ICH), are a concern following EVT for MeVO.
  • The clinical impact of ICH on functional outcomes after EVT for MeVO requires elucidation.

Purpose of the Study:

  • To investigate the association between intracranial hemorrhage (ICH) after EVT for MeVO and functional outcomes.
  • To compare functional outcomes based on the presence and severity of ICH post-EVT for MeVO.

Main Methods:

  • A post hoc analysis of the Japan Registry of NeuroEndovascular Therapy 4 (JRNT4) was performed.
  • Included 2465 patients with MeVO who underwent EVT for acute ischemic stroke between 2015 and 2019.
  • Patients were categorized by ICH occurrence (none, asymptomatic, symptomatic) and functional outcomes (mRS, mortality) were assessed.

Main Results:

  • 12.6% of analyzed patients developed ICH, with 31.5% of those being symptomatic.
  • Both asymptomatic and symptomatic ICH were associated with a lower likelihood of favorable functional outcomes (mRS 0-2 at 30 days).
  • Adjusted odds ratios indicated significantly worse outcomes with symptomatic ICH (aOR 0.12) and a trend towards worse outcomes with asymptomatic ICH (aOR 0.77).

Conclusions:

  • Intracranial hemorrhage following EVT for MeVO is associated with worse functional outcomes, regardless of symptom presentation.
  • Developing optimal devices and techniques to minimize ICH during EVT for MeVO is critical.
  • Further research into reducing hemorrhagic complications is warranted to improve stroke treatment efficacy.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
20
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30